BALAXI vs JSLL: Stock Comparison
JEENA SIKHO LIFECARE is the larger company by market capitalisation. BALAXI PHARMA shows a lower P/E, while JEENA SIKHO LIFECARE shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
BALAXI leads 2; JSLL leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | BALAXI | JSLL |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | BALAXI | JSLL |
|---|---|---|
| Live Price | ₹21.96 | ₹322.3 |
| Day Change | 0.32% | -6.65% |
| Volume | 12,945 | 11.36 L |
| 52-Week High | ₹42.9 | ₹835 |
| 52-Week Low | ₹15.2 | ₹326 |
| Distance from 52W High | -48.81% | -61.4% |
Valuation
| Metric | BALAXI | JSLL |
|---|---|---|
| Market Cap | ₹121 Cr | ₹4,022 Cr |
| P/E Ratio | 12.63x | 16.94x |
| P/B Ratio | 0x | 8.58x |
| EPS | ₹0.24 | ₹5.31 |
| Book Value | ₹45.12 | ₹37.57 |
| Dividend Yield | 0% | 1.39% |
Growth
| Metric | BALAXI | JSLL |
|---|---|---|
| Revenue Growth (TTM YoY) | -25.76% | 54.8% |
| EPS Growth (TTM YoY) | -58.44% | 77.5% |
| Qtr Sales Growth | 0% | 0% |
| Qtr Profit Growth | 0% | 0% |
Profitability & Leverage
| Metric | BALAXI | JSLL |
|---|---|---|
| ROE | 0.57% | 47.48% |
| ROCE | 1.38% | 50.64% |
| Net Margin | 0.52% | 27.68% |
| Operating Margin | 3.4% | 38.71% |
| Debt to Equity | 0.22x | 0x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | BALAXI | JSLL |
|---|---|---|
| Promoter Holding | 65.99% | 63.67%▲ 0.05 pp |
| FII Holding | 0% | 4.5%▼ 0.28 pp |
| DII Holding | 2.56% | 0.53%▲ 0.17 pp |
| Public Holding | 31.45% | 31.3%▲ 0.07 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: BALAXI PHARMA and JEENA SIKHO LIFECARE.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.